Nasdaq: ARWR
Arrowhead Pharmaceuticals insiders
The officers, directors and 10% owners of Arrowhead Pharmaceuticals, Inc. who hold the most stock, valued at the live ARWR price.
$43.65
ARWR today +$540K (+1.25%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 11
- Their ARWR stock
- $254M
- Market value
- $6.15B
- Held by ranked insiders
- 4.14%
Insiders by value of ARWR holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Christopher Anzalone | Chief Executive Officer | 3,792,739 | $166M | 2.69% | 1025th |
| 2 | Patrick O'Brien | COO | 547,408 | $23.9M | 0.39% | 4533rd |
| 3 | Kenneth Myszkowski | Chief Financial Officer | 455,433 | $19.9M | 0.32% | 5216th |
| 4 | James Hamilton | Chief Medical Officer | 226,958 | $9.9M | 0.16% | 8850th |
| 5 | Javier San Martin | Chief Medical Officer | 198,497 | $8.7M | 0.14% | 9742nd |
| 6 | Daniel Joseph Apel | Chief Financial Officer | 162,905 | $7.1M | 0.12% | 11271st |
| 7 | Tracie Oliver | Chief Commercial Officer | 127,107 | $5.5M | <0.1% | 13467th |
| 8 | Douglas B. Given | Director | 124,167 | $5.4M | <0.1% | 13677th |
| 9 | Michael Perry | Director | 111,459 | $4.9M | <0.1% | 9889th |
| 10 | Douglas S. Ingram | Director | 46,215 | $2.0M | <0.1% | 6386th |
| 11 | Backer Marianne De | Director | 31,267 | $1.4M | <0.1% | 8334th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Arrowhead Pharmaceuticals; see each profile for the filing.